Biodegradable subcutaneous implant sticks for long-term blood pressure reduction
A biodegradable, long-acting technology, which is applied in the field of implant rods and biodegradable subcutaneous implant rods, can solve the problems of unstable blood pressure, difficult production process, and difficult drug release dose to meet the control standards, so as to weaken blood drug Concentration fluctuations, reducing liver toxicity, avoiding the effects of direct irritation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] Embodiment 1 (can produce 110 embedding rods by the formula of the present embodiment, the diameter of embedding rod is 3mm, and length is 40mm; The weight of every embedding rod is 0.3g, and every rod contains crude drug of 0.12g)
[0026] A biodegradable subcutaneous implant rod for long-acting blood pressure reduction, which is made of the following raw materials. The implant rod includes a carrier and a raw material drug. The carrier is modified polyglyceryl sebacate, which includes sebacic acid 15 g of acid, 5 g of glycerin, 0.1 g of 1,5-pentanediol, and raw materials including 4 g of losartan, 6 g of lacidipine, 2 g of enalapril, and 1 g of metoprolol.
[0027] Processing method of the present invention comprises the following steps:
[0028] The first step, the carrier is modified polyglyceryl sebacate. The processing method is to put 15g of sebacic acid, 5g of glycerin, and 0.1g of 1,5-pentanediol into the reaction kettle, and stir while heating. When the temp...
Embodiment 2
[0031] Embodiment 2 (can produce 200 embedding rods by the formula of the present embodiment, the diameter of embedding rod is 3mm, and length is 40mm; The weight of every embedding rod is 0.3g, and every rod contains crude drug of 0.15g)
[0032] A biodegradable subcutaneous implant rod for long-acting blood pressure reduction, which is made of the following raw materials, the implant rod includes a carrier and a raw material drug, and the carrier is modified polyglyceryl sebacate, which includes capric acid Diacid 20g, glycerol 10g, 1,5-pentanediol 0.1g; raw materials include losartan 11g, lacidipine 16g, enalapril 2g, metoprolol 1g.
[0033] The processing method of the present embodiment is the same as embodiment 1.
[0034] Implementation steps of the present invention:
PUM
Property | Measurement | Unit |
---|---|---|
diameter | aaaaa | aaaaa |
length | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com